Determining Treatment Options for Early-Stage Prostate Cancer
As the primary purveyors of prostate cancer treatment, urologists need to ensure their practices are set up to guide patients from diagnosis to treatment.
OncLiveTV
Dr. William Oh on the Symptoms of Prostate Cancer
William K. Oh, M.D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor ...
Mount Sinai Health System
Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
Dr Alibhai speaks with ecancertv at SIOG 2016 about the experience of men receiving abiraterone or docetaxel for the treatment of metastatic castrate resistant ...
ecancer
Comment: Urothelial cancer research from ASCO GU 2018
Dr Sonpavde speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium to comment on two bladder cancer studies presented at the meeting.
ecancer
Diagnostic and Prognostic Biomarkers
During this opening segment of a one-on-one interview series, Peter Salgo, MD, discusses emerging diagnostic and prognostic biomarkers in prostate cancer ...
AJMCtv
Risk Stratification for Early Detection of Prostate Cancer - EAU 15
EAU TV caught up with Sigrid Carlsson, Memorial Sloan-Kettering Cancer Center, New York, at EAU 15 about her work refining the way patients are tested for ...
WebsEdgeHealth
Men’s Health Month: What To Know About Prostate Cancer - Live Chat
This Live Chat features members of the University of Michigan Rogel Cancer Center's multidisciplinary urologic oncology team. You can ask your questions on ...
Michigan Medicine
Dr. William Oh on What to Ask About Prostate Cancer
William K. Oh, M.D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor ...
Mount Sinai Health System
Dr. Stephen Freedland Describes Treating Early-Stage Prostate Cancer
Stephen J. Freedland, MD, Associate Professor of Surgery, Associate Professor in Pathology, Duke University School of Medicine, discusses the complications ...
OncLiveTV
Advanced Prostate Cancer: Living Longer, Living Better
Treatment options for advanced prostate cancer.
Chesapeake Urology
Prostate Cancer research at TGen
Prostate Cancer is a deadly disease that took the lives of nearly 31000 American men in 2001. It is estimated that more than 230000 new cases will be ...
tgenvideo
Prostate cancer stage in advanced prostate cancer
Jim Marshall, a man with recurrent locally advanced prostate cancer, gives his take on cancer stage. Jim is not a doctor. This shorter version does not include the ...
JimJimJimJim
Preventing Skeletal-Related Events in Prostate Cancer
Panelists discuss the prevention of the skeletal-related events associated with androgen deprivation therapy-related bone mineral density loss in patients with ...
OncLiveTV
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer
Dr Choudhury speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about the challenges faced when attempting to select patients who ...
ecancer
Dr. Oh on Recognizing Symptom Burden in Advanced Prostate Cancer
William K. Oh, MD, professor of Medicine, Hematology, and Medical Oncology, and Urology, Mount Sinai Hospital, discusses a global study aimed at ...
OncLiveTV
Why should you research treatment and get a second opinion for prostate cancer? (William See, MD)
William See, MD, urologic surgeon, explains why you should do your research and get a second opinion after a prostate cancer diagnosis. Dr. See is part of the ...
Froedtert & the Medical College of Wisconsin
ASCO 2010: Prognostic and predictive markers in breast cancer
Dr Christoph Thomssen - Martin-Luther University, Halle, Germany Dr Thomssen discusses the difficulties faced when developing personalised medicine and ...
ecancer
TRACO: Prostate cancer and CAR-T cells
TRACO: Prostate cancer and CAR-T cells Air date: Thursday, October 17, 2019, 4:00:00 PM Category: TRACO Runtime: 01:32:31 Description: Prostate cancer ...
NIH VideoCast
Bladder Cancer: The Basics | Johns Hopkins Greenberg Bladder Cancer Institute
Specialists at the Johns Hopkins Greenberg Bladder Cancer Institute (GBCI) outline a basic overview of the functions of the bladder, and the different types of ...
Johns Hopkins Medicine
Factors To Consider When Deciding On Treatment For Prostate Cancer
When deciding on a treatment plan to address prostate cancer, you should take time to discuss your options with your doctor, and weigh both the advantages ...
Dr. DAVID B. SAMADI
Prognostic Indicators in Pancreatic Neuroendocrine Tumors
James C. Yao, MD; Matthew H. Kulke, MD; and Jonathan R. Strosberg, MD, describe several indicators that help guide prognosis in patients with pancreatic ...
OncLiveTV
Update on U.S. Cancer Survival Statistics | Did You Know?
Did you know cancer survival rates can vary based on race, ethnicity, and even where you live, and that the survival rates for the most common cancers overall ...
National Cancer Institute
ASCO GU 2019: updates on treatment and management of bladder cancer
Professor Matthew Galsky chairs a discussion with Professor Ananya Choudhury, Professor Joaquim Bellmunt and Dr Andrea Necchi on the latest data ...
ecancer
Lung Cancer - Sonoran Living | Dr. Puneet Bhalla & Dr. Mark Ono
On November 14th, Ironwood providers Dr. Bhalla and Dr. Ono Appear on ABC 's Sonoran Living to discuss Lung Cancer. November is Lung Cancer ...
Ironwood Cancer & Research Centers
Elahe Mostaghel - Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
Watch on LabRoots at: http://labroots.com/user/webinars/details/id/100 While androgen deprivation therapy (ADT) remains the primary treatment modality for ...
LabRoots
Prostate Cancer FAQ Part 2
Prostate Cancer: Frequently Asked Questions Part 2 How are prostate cancer tumours classified? Prostate tumours are classified according to the tumour stage ...
Dr. DAVID B. SAMADI
Screening in familial and hereditary pancreatic cancer
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Margaret A. Tempero discusses screening in familial and hereditary ...
ImedexCME
COU-AA-302: Abiraterone in Pre-Chemo CRPC
Charles J. Ryan, MD, describes data on the use of abiraterone from the COUGAR-302 study.
OncLiveTV
The discovery of new biomarkers for predicting outcomes in breast cancer
In patients with early stage breast cancer, there is a need to identify prognostic factors to determine the risk of recurrence and predictive factors to determine the ...
EMG-Health
What are the risk factors for pancreatic cancer? (Douglas Evans, MD)
Douglas Evans, MD, Medical College of Wisconsin surgical oncologist, describes the risk factors associated with pancreatic cancer. Dr. Evans is part of the ...
Froedtert & the Medical College of Wisconsin
ASCO 2019: Dr. Shah Covers Potentially Practice-Changing GI Cancer Studies
Manish A. Shah, MD, director of gastrointestinal (GI) oncology and chief of Solid Tumor Service at Weill Cornell Medicine/NewYork-Presbyterian Hospital, ...
OncLiveTV
Dr. Oh on a Biomarker Development Trial in mCRPC
William K. Oh, MD, professor of medicine, hematology and medical oncology, urology, The Mount Sinai Hospital, discusses a biomarker development trial in ...
OncLiveTV
Prostate Cancer Treatment (03): Patterns of Spread
Alta Bates Summit Medical Center, Oakland and Berkeley, CA Prostate Cancer Treatment Options (03): Patterns of Spread Video for Men Recently Diagnosed ...
Alta Bates Summit Medical Center
Acute Lymphocytic Leukemia: Strategies for the Difficult-to-Treat Patient
Earn CME: https://www.naccme.com/program/19-lm-04 In this webcast from the 'Recent Advances in Acute Leukemia Management' symposium during the 2019 ...
ImedexCME
Prognostic biomarkers will detect lung cancer at earlier stages
Visit http://www.ecancer.org for more. Prof Veronesi (European Institute of Oncology, Milan, Italy) talks to ecancertv at ESMO 2014 on her research on ...
ecancer
My experience of a clinical trial - Amy and Poppy
To find out more about clinical trials visit http://www.cancerresearchuk.org/cancer-help/trials/ Poppy is a fun-loving, adventurous, excitable 8 year old child.
Cancer Research UK
Siegfried Hauch-The molecular analysis on circulating tumor cells to determine prognostic and predic
Circulating tumor cells (CTCs) is an emerging source used molecular cancer diagnostics. Through expression profiling of CTCs, it allows a deeper ...
LabRoots
ROR1 and its role in CLL and other cancers
Thomas Kipps, MD, PhD, from University of California, San Diego, CA, talks to us about ROR1, an embryonic protein involved in the development of chronic ...
VJHemOnc – Video Journal of Hematological Oncology
Therapeutic Options in Metastatic CRPC
Charles J. Ryan, MD, discusses the treatment options available for progressive metastatic castration-resistant prostate cancer.
OncLiveTV
Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers
Visit http://www.ecancer.org for more. Prof Cmelak talks to ecancertv at ASCO 2014 about the findings of an NIH-funded phase II study which suggest that certain ...
ecancer
Insights into Cancer: Pancreatic Cancer 2016
Pancreatic cancer is the fourth most common cause of cancer related deaths in the United States. It is the second most common cause of gastrointestinal ...
UCLA Jonsson Comprehensive Cancer Center
Renal cell carcinoma trial analysis: current landscape of immunotherapy combinations
Toni Choueiri, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses various immunotherapy combinations showing promising results in early and late ...
VJOncology
